Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo

Clinical trial NCT04971200 · COMPLETED

Trial details

NCT number: NCT04971200
Sponsor: Premier Specialists, Australia
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Skin and Connective Tissue Diseases Skin Diseases Pigmentation Disorder Hypopigmentation Biologic Vitiligo

Start date: 2021-09-16
Primary completion: 2024-11-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.